Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Ovarian cancer: epigenetics, drug resistance, and progression
Weiwei Xie, Huizhen Sun, Xiaoduan Li, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 64

Showing 1-25 of 64 citing articles:

Post‐translational modifications of histones: Mechanisms, biological functions, and therapeutic targets
Ruiqi Liu, Jiajun Wu, H. Henry Guo, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 104
Writers, readers, and erasers RNA modifications and drug resistance in cancer
Di Chen, Xinyu Gu, Yeltai Nurzat, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 18
Long non-coding RNAs (lncRNAs); roles in tumorigenesis and potentials as biomarkers in cancer diagnosis
Sajad Najafi, Seyyed Hossein Khatami, Marjan Khorsand, et al.
Experimental Cell Research (2022) Vol. 418, Iss. 2, pp. 113294-113294
Closed Access | Times Cited: 62
Fatty Acid Metabolism in Ovarian Cancer: Therapeutic Implications
Hyunho Yoon, Sanghoon Lee
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 4, pp. 2170-2170
Open Access | Times Cited: 61
CRABP2 affects chemotherapy resistance of ovarian cancer by regulating the expression of HIF1α
Xin Fu, Qian Zhang, Zhaosong Wang, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11
Mechanistic insights into epithelial-mesenchymal transition mediated cisplatin resistance in ovarian cancer
Taha Umair Wani, Hyun‐Yi Kim, Geum-Hwa Lee, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Exosomes in diagnostic and therapeutic applications of ovarian cancer
Dhaval Bhavsar, Rajeswari Raguraman, Dongin Kim, et al.
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 7
The Application of Nanoparticle‐Based Imaging and Phototherapy for Female Reproductive Organs Diseases
Lihua Luo, Huan‐Li Zhou, Sijie Wang, et al.
Small (2023)
Closed Access | Times Cited: 14
A methylation- and immune-related lncRNA signature to predict ovarian cancer outcome and uncover mechanisms of chemoresistance
Lu Chen, Wujiang Gao, Lin Li, et al.
Journal of Ovarian Research (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 13
Emerging Roles of m6A RNA Methylation Regulators in Gynecological Cancer
Wanjun Huang, Fanhua Kong, Ruolan Li, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 22
Molecular Management of High-Grade Serous Ovarian Carcinoma
Paula Punzón-Jiménez, Víctor Lago, Santiago Domingo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13777-13777
Open Access | Times Cited: 19
Prevalence of Helicobacter pylori infection in China from 2014-2023: A systematic review and meta-analysis
Lu Xie, Guangwei Liu, Yanan Liu, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 43, pp. 4636-4656
Closed Access | Times Cited: 4
Promising new drugs and therapeutic approaches for treatment of ovarian cancer—targeting the hallmarks of cancer
Julia S. Hillmann, Nicolaì Maass, Dirk Bauerschlag, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
A comprehensive review of traditional medicinal plants and their role in ovarian cancer treatment
Banuppriya Palani, Renu Vajjiravelu, Rajeshkumar Shanmugam, et al.
South African Journal of Botany (2025) Vol. 181, pp. 426-445
Closed Access
Advancing ovarian cancer management: Role of nucleic acid biomarkers and novel therapeutic approaches
Rutuja Deshmukh, Sharav Desai, Vipul Patel, et al.
Gene Reports (2025), pp. 102241-102241
Closed Access
The diverse effects of cisplatin on tumor microenvironment: Insights and challenges for the delivery of cisplatin by nanoparticles
Xinxin Meng, Feng‐Yun Ma, Dingli Yu
Environmental Research (2023) Vol. 240, pp. 117362-117362
Closed Access | Times Cited: 10
Anti-cancer activity of capsaicin and its analogs in gynecological cancers
Kathleen C. Brown, Amanda M. Sugrue, Kaitlyn Conley, et al.
Advances in cancer research (2024), pp. 241-281
Closed Access | Times Cited: 3
Extraterrestrial Gynecology: Could Spaceflight Increase the Risk of Developing Cancer in Female Astronauts? An Updated Review
Rosa Drago‐Ferrante, Riccardo Di Fiore, Fathi Karouia, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7465-7465
Open Access | Times Cited: 16
Emerging role of m6A methylation modification in ovarian cancer
Linlin Chang, Xiaqing Xu, Xueling Liu, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Progress in Applicability of Scoring Systems Based on Nutritional and Inflammatory Parameters for Ovarian Cancer
Juan Mu, Yue Wu, Chen Jiang, et al.
Frontiers in Nutrition (2022) Vol. 9
Open Access | Times Cited: 11
Promoting action of long non-coding RNA small nucleolar RNA host gene 4 in ovarian cancer
Chao Liu, Zhao Shu, Zhi Xiang Lv, et al.
Acta Biochimica Polonica (2023)
Open Access | Times Cited: 6
A comprehensive survey into the role of microRNAs in ovarian cancer chemoresistance; an updated overview
Ahmad Saburi, Mohammad Saeed Kahrizi, Navid Naghsh, et al.
Journal of Ovarian Research (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Long noncoding RNAs as therapeutic targets to overcome chemoresistance in ovarian cancer
Linjiao Chen, Jie Wang, Qian Liu
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 9
First-in-Human Dose-Escalation Study of the Novel Oral Depsipeptide Class I-Targeting HDAC Inhibitor Bocodepsin (OKI-179) in Patients with Advanced Solid Tumors
Anna Schreiber, Jodi A. Kagihara, Bradley R. Corr, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 91-91
Open Access | Times Cited: 5
The downregulation of miR-509-3p expression by collagen type XI alpha 1-regulated hypermethylation facilitates cancer progression and chemoresistance via the DNA methyltransferase 1/Small ubiquitin-like modifier-3 axis in ovarian cancer cells
Yi‐Hui Wu, Yu-Fang Huang, Pei‐Ying Wu, et al.
Journal of Ovarian Research (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top